Method of treatment of parkinson's disease

2-amino-N-(1,2-diphenyl-1-methylethyl) acetamide (remacemide) or a phamaceutically acceptable salt thereof, and L-dopa, are useful in conjunction with one another in the treatment of Parkinson's disease. Pharmaceutical products and formulations comprising these active agents are provided.

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: JOHNSON, PETER, WATKINS, BARRY E, HARRIS, ERIC W
Format: Patent
Sprache:eng
Schlagworte:
Online-Zugang:Volltext bestellen
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page
container_issue
container_start_page
container_title
container_volume
creator JOHNSON
PETER
WATKINS
BARRY E
HARRIS
ERIC W
description 2-amino-N-(1,2-diphenyl-1-methylethyl) acetamide (remacemide) or a phamaceutically acceptable salt thereof, and L-dopa, are useful in conjunction with one another in the treatment of Parkinson's disease. Pharmaceutical products and formulations comprising these active agents are provided.
format Patent
fullrecord <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_US5650443A</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>US5650443A</sourcerecordid><originalsourceid>FETCH-epo_espacenet_US5650443A3</originalsourceid><addsrcrecordid>eNrjZNDyTS3JyE9RyE9TKClKTSzJTc0rAXEKEouyM_OK8_PUixVSMotTE4tTeRhY0xJzilN5oTQ3g7yba4izh25qQX58anFBYnJqXmpJfGiwqZmpgYmJsaMxYRUAhgQoPQ</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>Method of treatment of parkinson's disease</title><source>esp@cenet</source><creator>JOHNSON; PETER ; WATKINS; BARRY E ; HARRIS; ERIC W</creator><creatorcontrib>JOHNSON; PETER ; WATKINS; BARRY E ; HARRIS; ERIC W</creatorcontrib><description>2-amino-N-(1,2-diphenyl-1-methylethyl) acetamide (remacemide) or a phamaceutically acceptable salt thereof, and L-dopa, are useful in conjunction with one another in the treatment of Parkinson's disease. Pharmaceutical products and formulations comprising these active agents are provided.</description><edition>6</edition><language>eng</language><subject>HUMAN NECESSITIES ; HYGIENE ; MEDICAL OR VETERINARY SCIENCE ; PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><creationdate>1997</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&amp;date=19970722&amp;DB=EPODOC&amp;CC=US&amp;NR=5650443A$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,309,781,886,25568,76551</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&amp;date=19970722&amp;DB=EPODOC&amp;CC=US&amp;NR=5650443A$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>JOHNSON; PETER</creatorcontrib><creatorcontrib>WATKINS; BARRY E</creatorcontrib><creatorcontrib>HARRIS; ERIC W</creatorcontrib><title>Method of treatment of parkinson's disease</title><description>2-amino-N-(1,2-diphenyl-1-methylethyl) acetamide (remacemide) or a phamaceutically acceptable salt thereof, and L-dopa, are useful in conjunction with one another in the treatment of Parkinson's disease. Pharmaceutical products and formulations comprising these active agents are provided.</description><subject>HUMAN NECESSITIES</subject><subject>HYGIENE</subject><subject>MEDICAL OR VETERINARY SCIENCE</subject><subject>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>1997</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNrjZNDyTS3JyE9RyE9TKClKTSzJTc0rAXEKEouyM_OK8_PUixVSMotTE4tTeRhY0xJzilN5oTQ3g7yba4izh25qQX58anFBYnJqXmpJfGiwqZmpgYmJsaMxYRUAhgQoPQ</recordid><startdate>19970722</startdate><enddate>19970722</enddate><creator>JOHNSON; PETER</creator><creator>WATKINS; BARRY E</creator><creator>HARRIS; ERIC W</creator><scope>EVB</scope></search><sort><creationdate>19970722</creationdate><title>Method of treatment of parkinson's disease</title><author>JOHNSON; PETER ; WATKINS; BARRY E ; HARRIS; ERIC W</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_US5650443A3</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>eng</language><creationdate>1997</creationdate><topic>HUMAN NECESSITIES</topic><topic>HYGIENE</topic><topic>MEDICAL OR VETERINARY SCIENCE</topic><topic>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</topic><toplevel>online_resources</toplevel><creatorcontrib>JOHNSON; PETER</creatorcontrib><creatorcontrib>WATKINS; BARRY E</creatorcontrib><creatorcontrib>HARRIS; ERIC W</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>JOHNSON; PETER</au><au>WATKINS; BARRY E</au><au>HARRIS; ERIC W</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>Method of treatment of parkinson's disease</title><date>1997-07-22</date><risdate>1997</risdate><abstract>2-amino-N-(1,2-diphenyl-1-methylethyl) acetamide (remacemide) or a phamaceutically acceptable salt thereof, and L-dopa, are useful in conjunction with one another in the treatment of Parkinson's disease. Pharmaceutical products and formulations comprising these active agents are provided.</abstract><edition>6</edition><oa>free_for_read</oa></addata></record>
fulltext fulltext_linktorsrc
identifier
ispartof
issn
language eng
recordid cdi_epo_espacenet_US5650443A
source esp@cenet
subjects HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
title Method of treatment of parkinson's disease
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-16T18%3A47%3A52IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=JOHNSON;%20PETER&rft.date=1997-07-22&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3EUS5650443A%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true